Skip to main content
SpringerLink
Log in

Antidepressiva

  • Chapter
Kompendium der Psychiatrischen Pharmakotherapie

  • 5331 Accesses

Zusammenfassung

Antidepressiva sind eine heterogene Gruppe von Pharmaka, die bei depressiven Syndromen unterschiedlicher nosologischer Zuordnung und Charakteristik einen stimmungsaufhellenden und/oder antriebsverbessernden Therapieeffekt haben. Zusätzlich sind sie bei einer Reihe weiterer Störungsbilder wirksam, sodass der Begriff »Antidepressiva« nur einen Teilaspekt ihrer therapeutischen Potenz darstellt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Aan Het Rot M, Zarate CA Jr, Charney DS, Mathew SJ (2012) Ketamine for depression: where do we go from here? Biol Psychiatry 72(7):537–547

    Article  Google Scholar 

  • Barth J, Munder T, Gerger H et al (2013) Comparative efficacy of seven psychotherapeutic interventions for patients with depression: a network meta-analysis. PLoS Med 10(5):e1001454

    Article  Google Scholar 

  • Benkert O (2009) StressDepression. Beck, München

    Google Scholar 

  • Bloch MH, Hannestad J (2012) Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis. Mol Psychiatry 17(12):1272–1282

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Brasky TM, Darke AK, Song X et al (2013) Plasma phospholipids fatty acids and prostate cancer risk in the SELECT trial. J Natl Cancer Inst 105(15):1132–1141

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Brunoni AR, Valiengo L, Baccaro A et al (2013) The sertraline vs. electrical current therapy for treating depression clinical study: results from a factorial, randomized, controlled trial. JAMA Psychiatry 70(4):383–391

    Article  CAS  PubMed  Google Scholar 

  • Castro VM, Clements CC, Murphy SN et al (2013) QT interval and antidepressant use: a cross sectional study of electronic health records. BMJ 346: f288

    Google Scholar 

  • Chollet F, Tardy J, Albucher JF et al (2011) Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol 10(2):123–130

    Article  CAS  PubMed  Google Scholar 

  • Cipriani A, Purgato M, Furukawa TA et al (2012) Citalopram versus other anti-depressive agentsfor depression. Cochrane Database Syst Rev 7:CD006534

    Google Scholar 

  • Cooney GM, Dwan K, Greig CA et al (2013) Exercise for depression. Cochrane Database Syst Rev 9:CD004366

    Google Scholar 

  • Cuijpers P, Sijbrandij M, Koole SL et al (2013) The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: a meta-analysis of direct comparisons. World Psychiatry 12(2):137–148

    Article  PubMed Central  PubMed  Google Scholar 

  • Cuijpers P, Sijbrandij M, Koole SL et al (2014) Adding psychotherapy to antidepressant medication in depression and anxietydisorders: a meta-analysis. World Psychiatry 13(1):56–67

    Article  PubMed Central  PubMed  Google Scholar 

  • Diener H-C, Weimar C (Hrsg) (2012) Leitlinien für Diagnostik und Therapie in der Neurologie. Herausgegeben von der Kommission »Leitlinien« der Deutschen Gesellschaft für Neurologie, Thieme, Stuttgart

    Google Scholar 

  • Driessen E, Van HL, Don FJ et al (2013) The efficacy of cognitive-behavioral therapy and psychodynamic therapy in the outpatient treatment of major depression: a randomized clinical trial. Am J Psychiatry 170(9):1041–1050

    Google Scholar 

  • Deuschle M (2013) Effects of antidepressants on glucose metabolism and diabetes mellitus type 2 in adults. Curr Opin Psychiatry 26(1):60–65

    Article  PubMed  Google Scholar 

  • Dold M, Aigner M, Lanzenberger R, Kasper S (2013) Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials. Int J Neuropsychopharmacol 16(3):557–574

    Article  CAS  PubMed  Google Scholar 

  • Gartlehner G, Hansen RA, Morgan LC et al (2011) Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis. Ann Intern Med 155(11):772–875

    Article  PubMed  Google Scholar 

  • Ghaleiha A, Entezari N, Modabbernia A et al (2013) Memantine add-on in moderate to severe obsessive-compulsive disorder: randomized double-blind placebo-controlled study. J Psychiatr Res 47(2):175–180

    Article  PubMed  Google Scholar 

  • Gibbons RD, Hur K, Brown CH et al (2012a) Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine. Arch Gen Psychiatry 69(6):572–579

    CAS  Google Scholar 

  • Gibbons RD, Brown CH, Hur K et al (2012b) Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine. Arch Gen Psychiatry 69(6):580–587

    Article  CAS  Google Scholar 

  • Girardin FR, Gex-Fabry M, Berney P et al (2013) Drug-induced long QT in adult psychiatric inpatients: the 5-year cross-sectional ECG Screening Outcome in Psychiatry study. Am J Psychiatry 170(12):1468–1476

    Article  PubMed  Google Scholar 

  • Guaiana G, Gupta S, Chiodo D et al (2013) Agomelatine versus other antidepressive agents for major depression. Cochrane Database Syst Rev 12:CD008851

    Google Scholar 

  • Hackam DG, Mrkobrada M (2012) Selective serotonin reuptake inhibitors and brain hemorrhage: a meta-analysis. Neurology 79(18):1862–1865

    Article  CAS  PubMed  Google Scholar 

  • Hiemke C, Baumann P, Bergemann N et al (2011) AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011. Pharmacopsychiatry 44(6):195–235

    Article  Google Scholar 

  • Jarrett RB, Minhajuddin A, Gershenfeld H et al (2013) Preventing depressive relapse and recurrence in higher-risk cognitive therapy responders: a randomized trial of continuation phase cognitive therapy, fluoxetine, or matched pill placebo. JAMA Psychiatry 70(11):1152–1160

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Koesters M, Guaiana G, Cipriani A et al (2013) Agomelatine efficacy and acceptability revisited: systematic review and meta-analysis of published andunpublished randomised trials. Br J Psychiatry 203:179–187

    Article  PubMed  Google Scholar 

  • Kok RM, Nolen WA, Heeren TJ (2012) Efficacy of treatment in older depressed patients: a systematic review and meta-analysis of double-blind randomized controlled trials with antidepressants. J Affect Disord 141(2–3):103–115

    Article  CAS  PubMed  Google Scholar 

  • Kupfer DJ (1991) Long-term treatment of depression. J Clin Psychiatry 52(Suppl 5):28–34

    PubMed  Google Scholar 

  • Lara DR, Bisol LW, Munari LR (2013) Antidepressant, mood stabilizing and precognitive effects of very low dose sublingual ketamine in refractory unipolar and bipolar depression. Int J Neuropsychopharmacol 16(9):2111–2117

    Article  CAS  PubMed  Google Scholar 

  • Marjoribanks J, Brown J, O’Brien PM, Wyatt K (2013) Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev 6:CD001396

    Google Scholar 

  • Mead GE, Hsieh CF, Lee R et al (2013) Selective serotonin reuptake inhibitors for stroke recovery: a systematic review and meta-analysis. Stroke 44(3):844–850

    Article  PubMed  Google Scholar 

  • Miller M, Swanson SA, Azrael D et al (2014) Antidepressant Dose, Age, and the Risk of Deliberate Self-harm. JAMA Intern Med 174(6):899–909

    Article  CAS  PubMed  Google Scholar 

  • Mortensen JK, Larsson H, Johnsen SP, Andersen G (2013) Post stroke use of selective serotonin reuptake inhibitors and clinical outcome among patients with ischemic stroke: a nationwide propensity score-matched follow-up study. Stroke 44(2):420–442

    Article  CAS  PubMed  Google Scholar 

  • Nelson JC, Delucchi KL, Schneider LS( 2013) Moderators of outcome in late-life depression: a patient-level meta-analysis. Am J Psychiatry 170(6): 651–659

    Google Scholar 

  • Porsteinsson AP, Drye LT, Pollock BG et al; CitAD Research Group (2014) Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial. JAMA 311(7): 682–691

    Google Scholar 

  • Rodriguez CI, Kegeles LS, Levinson A et al (2013) Randomized controlled crossover trial

    Google Scholar 

  • of ketamine inobsessive-compulsive disorder: proof-of-concept. Neuropsychopharmacology38(12): 2475–2483

    Google Scholar 

  • Simpson HB, Foa EB, Liebowitz MR et al (2013) Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial. JAMA Psychiatry 70(11):1190–1199

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Stewart JW, McGrath PJ, Blondeau C et al (2014) Combination antidepressant therapy for major depressive disorder: Speed and probability of remission. J Psychiatr Res 57:7–14

    Article  Google Scholar 

  • Stingl JC, Brockmöller J (2013) Personalisierte Pharmakotherapie. Evidenzbasierte Leitlinien und klinische Anwendung pharmakogenetischer Diagnostik. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 56(11):1509–1521

    Article  CAS  PubMed  Google Scholar 

  • Voican CS, Corruble E, Naveau S, Perlemuter G (2014) Antidepressant-Induced Liver Injury: A Review for Clinicians. Am J Psychiatry 171(4):404–415

    Article  PubMed  Google Scholar 

  • von Wolff A, Hölzel LP, Westphal A et al (2013) Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment ofchronic depression and dysthymia: a systematic review and meta-analysis. J AffectDisord 144(1–2): 7–15

    Google Scholar 

  • Wang YP, Chen YT, Tsai CF et al (2014) Short-term use of serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding. Am J Psychiatry 171(1):54–61

    Article  PubMed  Google Scholar 

  • Watts BV, Schnurr PP, Mayo L et al (2013) Meta-analysis of the efficacy of treatments for posttraumatic stress disorder. J Clin Psychiatry 74(6):e541–e550

    Article  PubMed  Google Scholar 

  • Wenzel-Seifert K, Wittmann M, Haen E (2011) QTc prolongation by psychotropic drugs and the risk of Torsades de Pointes. Dtsch Arztebl Int 108(41):687–693

    PubMed Central  PubMed  Google Scholar 

  • Wiles N, Thomas L, Abel A et al (2013) Cognitive behavioural therapy as an adjunct to pharmacotherapy for primary care based patients with treatment resistant depression: results of the CoBalT randomised controlled trial. The Lancet 381(9864):375–384

    Article  Google Scholar 

  • WHO (World Health Organization and United Nations High Commissioner for Refugees) (2013) Assessment and Management of Conditions Specifically Related to Stress: mhGAP Intervention Guide Module (version 1.0). Geneva

    Google Scholar 

  • Zivin K, Pfeiffer PN, Bohnert AS et al (2013) Evaluation of the FDA warning against prescribing citalopram at doses exceeding 40 mg. Am J Pschiatry 170(6):642–650

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Mainz

    O. Benkert

Authors
  1. O. Benkert
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Benkert, O. (2015). Antidepressiva. In: Kompendium der Psychiatrischen Pharmakotherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54769-0_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-54769-0_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-54768-3

  • Online ISBN: 978-3-642-54769-0

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation